Skip to main content

Evidence for Enhanced Oxidative Stress in Coronary Heart Disease and Chronic Heart Failure

  • Chapter
Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 525))

Abstract

Oxidation injury has been claimed as one of the key factors in the development of coronary heart disease and chronic heart failure [1,2]. The isoprostane 8-epi-PGF2 is gaining increasing interest as reliable marker of in-vivo oxidation injury [3]. As it causes among others coronary vasoconstriction [4] its pathophysiological role may become even more important. We therefore assessed the isoprostane 8-epi-PGF in arteries, veins, heart valves and myocardial tissue immunochemically as well as by immunohistochemistry. Furthermore, 8-epi-PGF was determined in plasma and urine of patients with CHD compared to patients with dilated and ischemic CMP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cracowski JL, Tremel F, Marpeau C, et al. Increased formation of F2-isoprostanes in patients with severe heart failure. Heart 2000; 84: 439–440.

    Article  PubMed  CAS  Google Scholar 

  2. McMurray J, Chopra M, Abdullah I. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993; 14: 1493–1498.

    Article  PubMed  CAS  Google Scholar 

  3. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36: 1–21.

    Article  PubMed  CAS  Google Scholar 

  4. Kromer BM, Tippins JR. Coronary artery constriction by the isoprostane 8-epi-PGF. Brit J Pharmacol 1996; 119: 1276–1280.

    Article  CAS  Google Scholar 

  5. Mehrabi MR, Ekmekcioglu C, Tatzber F, Oguogho A, Ullrich R, Morgan A, Tamaddon R, Grimm M, Glogar HD, Sinzinger H. The isoprosatne, 8-epi-PGF, is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovasc Res 1999; 43:492–499.

    Article  PubMed  CAS  Google Scholar 

  6. Mehrabi MR, Serbecic N, Ekmekcioglu C, Tamaddon F, Ullrich R, Sinzinger H, Glogar HD. The isoprostane 8-epi-PGF is a valuable indicator of oxidative injury in human heart valves. Cardiovasc Pathol 2001; 10: 241–245.

    Article  PubMed  CAS  Google Scholar 

  7. Wolfram R, Oguogho A, Palumbo B, Sinzinger H. Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by increased 8-epi-PGF. J Am Coll Cardiol 2003 (submitted).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wolfram, R., Oguogho, A., Palumbo, B., Sinzinger, H. (2003). Evidence for Enhanced Oxidative Stress in Coronary Heart Disease and Chronic Heart Failure. In: Yazici, Z., Folco, G.C., Drazen, J.M., Nigam, S., Shimizu, T. (eds) Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research. Advances in Experimental Medicine and Biology, vol 525. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9194-2_42

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9194-2_42

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4831-3

  • Online ISBN: 978-1-4419-9194-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics